Recxia Formulations Private Limited
About Recxia Formulations Private Limited
Data last updated:
Recxia Formulations Private Limited is a private limited company based in Amritsar, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2007PTC031183. Its GSTIN is 03AADCR6952J1Z8 (Punjab). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Satish Chander Puri and Kamal Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 206 – Sunrise Plaza 1 – Cooper Road, Amritsar, Punjab, India – 143001.
As per the financials filed for FY 2025, the company reported a revenue of ₹94.97 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹70,000 (net margin 0.7%) and EBITDA of ₹1.07 Lakh (EBITDA margin 1.1%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years and 23% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Recxia Formulations Private Limited's registered office is in Amritsar, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address206 – Sunrise Plaza 1 – Cooper Road, Amritsar, Punjab, India – 143001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Recxia Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Recxia Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Recxia Formulations Private Limited, buy the company report.
Financials of Recxia Formulations Private Limited
FY 2024 filings availableRecxia Formulations Private Limited reported revenue of ₹94.97 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 20% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Recxia Formulations Private Limited, buy the company report.
Board of directors of Recxia Formulations Private Limited
Recxia Formulations has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Chander Puri | Director | 31 May 2007 | 19 Years 5 Months | Current |
| Kamal Sharma Also directs: Vecnost Biotechnology Private Limited | Director | 31 May 2007 | 19 Years 5 Months | Current |
| Manish Pahwa | Additional Director | 01 Dec 2021 | 4 Years 10 Months | Current |
| Pawan Kapoor Also directs: Sherim Squibss Pharma Private Limited | Additional Director | 01 Dec 2021 | 4 Years 10 Months | Current |
| Meenakshi Pahwa | Additional Director | 25 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Recxia Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stroff Pharmaceutical Private Limited | ₹95.3 Lakh (FY 2025) | 29.0% | Lucknow, Uttar Pradesh, India | |||
| Charissa Psion Pharmaceuticals Private Limited | ₹95.08 Lakh (FY 2018) | -25.0% | Chennai, Tamil Nadu, India | |||
| Recxia Formulations Private Limitedthis company | ₹94.97 Lakh (FY 2025) | ₹70,000 | 0.7% | -20.0% | 4 | Amritsar, Punjab, India |
| Cytochem Healthcare (India) Private Limited | ₹94.85 Lakh (FY 2024) | -5.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Recxia Formulations Private Limited, buy the company report.
Auditor
Recxia Formulations Private Limited is audited by V K WADHWA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V K WADHWA & CO. | FY 2023 | 040016N |
Shareholding
The shareholding of Recxia Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Recxia Formulations Private Limited, buy the company report.
Legal cases
Recxia Formulations Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Kinedex Healthcare Pvt. Ltd. | Pending |
To see the full case history of Recxia Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Recxia Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Recxia Formulations Private Limited has a workforce of 4 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Recxia Formulations has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCR6952J1Z8 | Punjab | Active | 01 Jul 2017 |
| 03AAKCS6314G1ZJ | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Recxia Formulations Private Limited, buy the company report.
Recent activity
Recxia Formulations Private Limited has 9 board changes on record since 2007: 5 appointments and 4 cessations. The latest: Meenakshi Pahwa was appointed as Additional Director on 25 Feb 2025.
Frequently asked questions
Recxia Formulations is an active private limited company based in Amritsar, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 May 2007 (19+ years old) and is registered under CIN U24232PB2007PTC031183.
Recxia Formulations has 5 current directors:
- Satish Chander Puri - Director
- Kamal Sharma - Director
- Manish Pahwa - Additional Director
- Pawan Kapoor - Additional Director
- Meenakshi Pahwa - Additional Director
The latest financial statements of Recxia Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Recxia Formulations is 03AADCR6952J1Z8, registered in Punjab. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 03AAKCS6314G1ZJ (Punjab).
The CIN (Corporate Identification Number) of Recxia Formulations is U24232PB2007PTC031183. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Recxia Formulations has 1 court case on record: 1 filed against it. 1 is pending.
Recxia Formulations was incorporated on 31 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Recxia Formulations by revenue are Stroff Pharmaceutical Private Limited, Charissa Psion Pharmaceuticals Private Limited, Cytochem Healthcare (India) Private Limited, all in the Chemicals industry (Chemical Retail and Distribution, Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Meenakshi Pahwa was appointed as Additional Director on 25 Feb 2025. Anupama Kapoor ceased to be Director on 01 Dec 2021. Manish Pahwa was appointed as Additional Director on 01 Dec 2021. Recxia Formulations has 9 board changes on record in total.
The registered office of Recxia Formulations is at 206 – Sunrise Plaza 1 – Cooper Road, Amritsar, Punjab, India – 143001.
Recxia Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
